• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain.

作者信息

Hall H, Sällemark M

出版信息

Pharmacol Toxicol. 1987 May;60(5):359-63. doi: 10.1111/j.1600-0773.1987.tb01527.x.

DOI:10.1111/j.1600-0773.1987.tb01527.x
PMID:2886988
Abstract

The effects of repeated oral administration to rats of three antipsychotic compounds (haloperidol 1 mumol/kg, raclopride 5 mumol/kg and remoxipride 10 mumol/kg) on agonist affinity states of the dopamine-D2 receptor were studied using 3H-spiperone binding to rat striatal homogenates in vitro. The competition between 3H-spiperone and dopamine was analyzed using the iterative nonlinear computer program LIGAND. The treatment of rats with haloperidol, raclopride and remoxipride caused an increased number of striatal dopamine-D2 receptors. In parallel to this increase in Bmax (approximately 50%) there was an increased fraction of the number of receptors being in the D2 (high) affinity state. The affinity of dopamine for the D2 (high) state was not affected while a significant decrease in affinity of dopamine for the D2 (low) state was found. The results are discussed in view of the mechanism of action of the three compounds and of neuroleptics in general.

摘要

相似文献

1
Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain.
Pharmacol Toxicol. 1987 May;60(5):359-63. doi: 10.1111/j.1600-0773.1987.tb01527.x.
2
Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.瑞莫必利及一些相关的新型取代水杨酰胺对大鼠脑受体的影响。
Acta Pharmacol Toxicol (Copenh). 1986 Jan;58(1):61-70. doi: 10.1111/j.1600-0773.1986.tb00071.x.
3
Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.瑞莫必利,一种在大鼠脑中具有选择性抗多巴胺能作用的新型潜在抗精神病化合物。
Eur J Pharmacol. 1984 Jul 20;102(3-4):459-74. doi: 10.1016/0014-2999(84)90567-3.
4
Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.新型选择性多巴胺D2受体配体——氟化取代苯甲酰胺[3H]NCQ 115的合成与结合特性
Eur J Pharmacol. 1991 Aug 16;201(1):1-10. doi: 10.1016/0014-2999(91)90315-h.
5
Biochemical pharmacology of the atypical neuroleptic remoxipride.
Acta Psychiatr Scand Suppl. 1990;358:27-36. doi: 10.1111/j.1600-0447.1990.tb05282.x.
6
Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
Eur J Pharmacol. 1989 Dec 7;173(2-3):177-82. doi: 10.1016/0014-2999(89)90516-5.
7
Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.氟哌啶醇、瑞莫必利和雷氯必利对大鼠脑内突触前和突触后多巴胺受体作用的比较。
Naunyn Schmiedebergs Arch Pharmacol. 1988 Apr;337(4):379-84. doi: 10.1007/BF00169527.
8
Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
Eur J Pharmacol. 1988 Jan 27;146(1):113-20. doi: 10.1016/0014-2999(88)90492-x.
9
Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors.
Eur J Pharmacol. 1993 Jul 6;238(1):121-5. doi: 10.1016/0014-2999(93)90515-j.
10
Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.一种苯甲酰胺类抗精神病药物[3H]-YM-09151-2选择性标记的多巴胺D2受体。
Naunyn Schmiedebergs Arch Pharmacol. 1985 Jun;329(4):333-43. doi: 10.1007/BF00496365.

引用本文的文献

1
Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist.非典型抗精神病药物瑞莫必利(一种多巴胺D2受体拮抗剂)的药理学
CNS Drug Rev. 2001 Fall;7(3):265-82. doi: 10.1111/j.1527-3458.2001.tb00199.x.
2
A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.氯氮平、氟哌啶醇和瑞莫必利对灵长类动物大脑皮层中D1和D2多巴胺能受体的共同作用。
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4353-6. doi: 10.1073/pnas.91.10.4353.
3
Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia.
瑞莫必利。对其药效学和药代动力学特性以及在精神分裂症中的治疗潜力的综述。
Drugs. 1990 Dec;40(6):863-79. doi: 10.2165/00003495-199040060-00008.
4
Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats.大鼠长期给予和停用典型及非典型抗精神病药物后脑受体区域变化的放射自显影分析。
J Neural Transm Gen Sect. 1990;82(2):93-109. doi: 10.1007/BF01245166.
5
NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.NCQ 298,一种用于标记多巴胺D2受体的新型选择性碘化水杨酰胺配体。
Psychopharmacology (Berl). 1991;103(1):6-18. doi: 10.1007/BF02244067.